An overview of lefamulin for the treatment of community acquired bacterial pneumonia
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1714592
Abstract: ABSTRACT Introduction Lefamulin is a novel antibiotic that belongs to the pleuromutilin class with excellent activity against all microorganisms, including atypical pathogens, that cause community-acquired pneumonia (CAP). Areas covered This article reviews the spectrum of… read more here.
Keywords: lefamulin; treatment; overview lefamulin; community acquired ... See more keywords